Berger JH - Search Results

1

Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.

Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D, DePinho RA. Bardeesy N, et al. Among authors: berger jh. Genes Dev. 2006 Nov 15;20(22):3130-46. doi: 10.1101/gad.1478706. Genes Dev. 2006. PMID: 17114584 Free PMC article.

2

Modeling INK4/ARF tumor suppression in the mouse.

Berger JH, Bardeesy N. Berger JH, et al. Curr Mol Med. 2007 Feb;7(1):63-75. doi: 10.2174/156652407779940477. Curr Mol Med. 2007. PMID: 17311533 Review.

3

Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma.

Kelly KA, Bardeesy N, Anbazhagan R, Gurumurthy S, Berger J, Alencar H, Depinho RA, Mahmood U, Weissleder R. Kelly KA, et al. PLoS Med. 2008 Apr 15;5(4):e85. doi: 10.1371/journal.pmed.0050085. PLoS Med. 2008. PMID: 18416599 Free PMC article.

4

LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.

Gurumurthy S, Hezel AF, Sahin E, Berger JH, Bosenberg MW, Bardeesy N. Gurumurthy S, et al. Among authors: berger jh. Cancer Res. 2008 Jan 1;68(1):55-63. doi: 10.1158/0008-5472.CAN-07-3225. Cancer Res. 2008. PMID: 18172296 Free PMC article.

5

Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.

Berger JH, Shi Y, Matsuura TR, Batmanov K, Chen X, Tam K, Marshall M, Kue R, Patel J, Taing R, Callaway R, Griffin J, Kovacs A, Hirenallur-Shanthappa D, Miller R, Zhang BB, Flach RJR, Kelly DP. Berger JH, et al. Sci Rep. 2025 Jan 2;15(1):422. doi: 10.1038/s41598-024-84515-9. Sci Rep. 2025. PMID: 39747575 Free PMC article.

6

Reply to Editorial Comment on "Evaluating Decision Regret in Patients Who Have Undergone Sacral Neuromodulation.

Johnson HM, McLain CA, Chong CH, Berger JH. Johnson HM, et al. Among authors: berger jh. Urology. 2024 Dec 31:S0090-4295(24)01216-0. doi: 10.1016/j.urology.2024.12.027. Online ahead of print. Urology. 2024. PMID: 39746491 No abstract available.

7

Beyond ketosis: the search for the mechanism underlying SGLT2-inhibitor benefit continues.

Berger JH, Finck BN. Berger JH, et al. J Clin Invest. 2024 Dec 16;134(24):e187097. doi: 10.1172/JCI187097. J Clin Invest. 2024. PMID: 39680453 Free PMC article.

8

Evaluating Decision Regret in Patients Who Have Undergone Sacral Neuromodulation.

Johnson HM, McLain CA, Chong CH, Berger JH. Johnson HM, et al. Among authors: berger jh. Urology. 2024 Oct 30:S0090-4295(24)00954-3. doi: 10.1016/j.urology.2024.10.067. Online ahead of print. Urology. 2024. PMID: 39486526

9

SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice.

Berger JH, Matsuura TR, Bowman CE, Taing R, Patel J, Lai L, Leone TC, Reagan JD, Haldar SM, Arany Z, Kelly DP. Berger JH, et al. Circ Res. 2024 Aug 16;135(5):632-634. doi: 10.1161/CIRCRESAHA.124.324823. Epub 2024 Jul 23. Circ Res. 2024. PMID: 39041214 No abstract available.

10

Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.

Zemet R, Hope KD, Edmondson AC, Shah R, Patino M, Yesso AM, Berger JH, Sarafoglou K, Larson A, Lam C, Morava E, Scaglia F. Zemet R, et al. Among authors: berger jh. Mol Genet Metab. 2024 Aug;142(4):108513. doi: 10.1016/j.ymgme.2024.108513. Epub 2024 Jun 13. Mol Genet Metab. 2024. PMID: 38917675 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters